MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS

被引:505
作者
CHEN, RT
MARKOWITZ, LE
ALBRECHT, P
STEWART, JA
MOFENSON, LM
PREBLUD, SR
ORENSTEIN, WA
机构
[1] CTR DIS CONTROL,CTR INFECT DIS,DIV VIRAL DIS,ATLANTA,GA 30333
[2] US FDA,CTR BIOL EVALUAT & RES,BETHESDA,MD 20014
[3] MASSACHUSETTS DEPT PUBL HLTH,DIV COMMUNICABLE DIS CONTROL,BOSTON,MA
关键词
D O I
10.1093/infdis/162.5.1036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A school blood drive before a measles outbreak permitted correlation of preexposure measles antibody titers with clinical protection using the plaque reduction neutralization (PRN) test and an EIA. Of 9 donors with detectable preexposure PRN titer ≤120, 8 met the clinical criteria for measles (7 seroconfirmed) compared with none of 71 with preexposure PRN titers >120 (P <.0001). Seven of 11 donors with preexposure PRN titers of 216–874 had a ≥-fold rise in antibody titer (mean, 43-fold) compared with none of 7 with a preexposure PRN titer ≥1052 (P <.02). Of 37 noncases with preexposure PRN titer <1052, 26 (70%) reported one or more symptoms compared with 11 (31%) of 35 donors with preexposure PRN titers ≥1052 (P <.002). By EIA, no case had detectable preexposure antibody; the preexposure geOlpetric mean titer of asymptomatic donors (220) was not significantly higher than that of symptomatic donors who did not meet the clinical criteria for measles (153) (P =.10). The study suggests that PRN titers ≤120 were not protective against measles disease and illness without rash due to measles may occur in persons with PRN titers above this level. © 1990, by The University of Chicago.
引用
收藏
页码:1036 / 1042
页数:7
相关论文
共 41 条
  • [1] PERSISTENCE OF MATERNAL ANTIBODY IN INFANTS BEYOND 12 MONTHS - MECHANISM OF MEASLES-VACCINE FAILURE
    ALBRECHT, P
    ENNIS, FA
    SALTZMAN, EJ
    KRUGMAN, S
    [J]. JOURNAL OF PEDIATRICS, 1977, 91 (05) : 715 - 718
  • [2] ROLE OF VIRUS-STRAIN IN CONVENTIONAL AND ENHANCED MEASLES PLAQUE NEUTRALIZATION TEST
    ALBRECHT, P
    HERRMANN, K
    BURNS, GR
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1981, 3 (05) : 251 - 260
  • [3] BELLANTI JA, 1985, IMMUNOLOGY, P566
  • [4] BRANDLIN.AD, 1973, JAMA-J AM MED ASSOC, V224, P616
  • [5] ANTIBODY-RESPONSE FOLLOWING MEASLES-MUMPS-RUBELLA VACCINE UNDER CONDITIONS OF CUSTOMARY USE
    BRUNELL, PA
    WEIGLE, K
    MURPHY, MD
    SHEHAB, Z
    COBB, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (11): : 1409 - 1412
  • [6] CLINICAL AND SEROLOGIC STUDY OF 103 CHILDREN WITH MEASLES VACCINE FAILURE
    CHERRY, JD
    FEIGIN, RD
    SHACKELFORD, PG
    HINTHORN, DR
    SCHMIDT, RR
    [J]. JOURNAL OF PEDIATRICS, 1973, 82 (05) : 802 - 808
  • [7] URBAN MEASLES IN VACCINE ERA - CLINICAL, EPIDEMIOLOGIC, AND SEROLOGIC STUDY
    CHERRY, JD
    SHIRLEY, RH
    SHACKELFORD, PG
    LOBES, LA
    LINS, RD
    HINTHORN, DR
    CHOI, SC
    FEIGIN, RD
    [J]. JOURNAL OF PEDIATRICS, 1972, 81 (02) : 217 - +
  • [8] CHERRY JD, 1972, PEDIATRICS, V50, P712
  • [9] ENZYME-IMMUNOASSAY VERSUS PLAQUE NEUTRALIZATION AND OTHER METHODS FOR DETERMINATION OF IMMUNE STATUS TO MEASLES AND VARICELLA-ZOSTER VIRUSES AND VERSUS COMPLEMENT-FIXATION FOR SERODIAGNOSIS OF INFECTIONS WITH THOSE VIRUSES
    CREMER, NE
    COSSEN, CK
    SHELL, G
    DIGGS, J
    GALLO, D
    SCHMIDT, NJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (06) : 869 - 874
  • [10] MEASLES REVACCINATION - PERSISTENCE AND DEGREE OF ANTIBODY TITER BY TYPE OF IMMUNE-RESPONSE
    DESEDATOUS, J
    CHERRY, JD
    SPENCER, MJ
    WELLIVER, RC
    BOYER, KM
    DUDLEY, JP
    ZAHRADNIK, JM
    KRAUSE, PJ
    WALBERGH, EW
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1978, 132 (03): : 287 - 290